News

Alzheimer’s blood test promises detection years before symptoms develop

February 1, 2018/

Amyloid beta deposits, or plaques, in the brain are the most commonly hypothesized causative agent behind Alzheimer’s disease. A new breakthrough blood test, developed by an international team of scientists, can reportedly measure the concentration of these amyloid beta concentrations using just a tiny blood sample.

Rich Haridy

https://newatlas.com/alzheimers-blood-test/53215/?utm_source=Gizmag+Subscribers&utm_campaign=ddaca4ec81-UA-2235360-4&utm_medium=email&utm_term=0_65b67362bd-ddaca4ec81-92465361

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

MATR Sponsor (view all)


"For small to medium to national organizations, for events and fundraisers of any size, in any format – live, virtual or hybrid – the platform is built for scale."

MATR Supporters (view all)


The Great Falls Development Alliance delivers aggressive, award-winning economic development support for business attraction, expansion, and retention.

Prospera's mission is to advance and inspire diverse economies and communities in southwest Montana.

Working closely with GFDA’s economic development team, HPF helps Montana businesses access the capital they need to expand, modernize, and strengthen local communities.